couter

BBRRFBlueberries Medical Corp.

Health CarePharmaceuticals
Oct 15, 2026 — Emergency Capital Raise / Dilution Risk
Chart by TradingView

The schedule

  • Thu15Oct

    Given critical liquidity constraints, the company faces a high likelihood of needing a dilutive equity offering or toxic debt issuance to fund operations.

  • Mon15Feb

    Anticipated sector-wide updates regarding federal specialty generic and cannabis-related scheduling under President Trump's administration.

  • Thu11Mar

    Q3 2026 financials release, testing whether the underlying business model can survive without continuous external capital injections.

  • Tue30Mar

    Full-year 2026 results release, carrying immense risk of auditor going-concern qualifications based on the strained balance sheet.

  • Thu10Jun
  • Thu9Sep

Past

  • Thu10Sep

    Blueberries Medical is estimated to report Q2 2026 earnings with a strict focus on cash burn and a revenue profile that recently contracted 22% YoY.